Verona Starts Phase 2b Trial to Test Nebulized Ensifentrine as Add-on Therapy
News
Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an add-on to a standard long-acting bronchodilator in people with moderate to severe ... Read more